Topic: drug manufacturing
While the FDA knows API production has mostly moved out of the U.S., it does not know how much is being produced in China or elsewhere.
India has come up with a surprise in the face of the coronavirus outbreak by curbing the export of 26 APIs and their formulations.
Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.
Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.
Advent, which bought Sanofi's Eastern European generics unit Zentiva for $2.2 billion last year, has now bought a Romanian drug maker from Alvogen.
With global recalls of tainted drugs growing more frequent, the consolidation of drug manufacturing abroad is raising eyebrows from U.S. regulators.
The way CEO Kåre Schultz figures it, Teva Pharmaceutical can make more manufacturing cuts after reaching its $3 billion cost reduction goal.
A manufacturing defect led to a 'softening' in response rates with a combo of its NKTR-214 and Opdivo in clinical trials, Nektar said.
With its oral semaglutide up for FDA review, Novo Nordisk is hunting for opportunities to boost its supply chain, and it found one in North Carolina.
With Yescarta on the market and other CAR-Ts on their way, Gilead’s Kite Pharma planted the flag for another manufacturing site.